These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9733595

  • 1. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT, Davies MG, Barber L, Svendsen E, Hagen PO.
    J Surg Res; 1998 Jul 01; 77(2):104-11. PubMed ID: 9733595
    [Abstract] [Full Text] [Related]

  • 2. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG, Dalen H, Barber L, Svendsen E, Hagen PO.
    J Surg Res; 1996 Jun 01; 63(1):128-36. PubMed ID: 8661185
    [Abstract] [Full Text] [Related]

  • 3. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
    Huynh TT, Iaccarino G, Davies MG, Svendsen E, Koch WJ, Hagen PO.
    Surgery; 1998 Aug 01; 124(2):177-86. PubMed ID: 9706136
    [Abstract] [Full Text] [Related]

  • 4. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD, Dassow MS, Seabrook GR, Jean-Claude JM, Towne JB, Cambria RA.
    J Surg Res; 2000 May 15; 90(2):183-90. PubMed ID: 10792961
    [Abstract] [Full Text] [Related]

  • 5. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG, Barber L, Dhanraj DN, Gettys TW, Ramkumar V, Hagen PO.
    J Surg Res; 1996 Jun 15; 63(1):115-22. PubMed ID: 8661183
    [Abstract] [Full Text] [Related]

  • 6. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
    Gulkarov I, Bohmann K, Cinnante KM, Pirelli L, Yu PJ, Grau JB, Pintucci G, Galloway AC, Mignatti P.
    J Surg Res; 2009 Jun 01; 154(1):150-6. PubMed ID: 18805551
    [Abstract] [Full Text] [Related]

  • 7. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D, Banno H, Nakayama M, Sugimoto M, Fujita H, Kobayashi M, Kuwano H, Komori K.
    J Vasc Surg; 2005 Oct 01; 42(4):757-64. PubMed ID: 16242565
    [Abstract] [Full Text] [Related]

  • 8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA, Petrofski JA, Schroder JN, Williams ML, Timberlake SH, Pippen A, Corwin MT, Solan AK, Jakoi A, Gehrig TR, Kontos CD, Milano CA.
    J Thorac Cardiovasc Surg; 2005 Jun 01; 129(6):1405-13. PubMed ID: 15942585
    [Abstract] [Full Text] [Related]

  • 9. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K, Shibata R, Takahashi N, Ouchi N, Maehara Y, Murohara T, Komori K.
    J Vasc Surg; 2011 Dec 01; 54(6):1753-9. PubMed ID: 21890304
    [Abstract] [Full Text] [Related]

  • 10. Reduction of experimental vein graft intimal hyperplasia by ketanserin.
    Massey MF, Davies MG, Svendsen E, Klyachkin ML, Schwartz LB, Barber L, McCann RL, Hagen PO.
    J Surg Res; 1993 Jun 01; 54(6):530-8. PubMed ID: 8412062
    [Abstract] [Full Text] [Related]

  • 11. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO.
    Surgery; 1994 Sep 01; 116(3):557-68. PubMed ID: 8079186
    [Abstract] [Full Text] [Related]

  • 12. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
    Fulton GJ, Davies MG, Koch WJ, Dalen H, Svendsen E, Hagen PO.
    J Vasc Surg; 1997 Mar 01; 25(3):453-63. PubMed ID: 9081126
    [Abstract] [Full Text] [Related]

  • 13. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
    Klyachkin ML, Davies MG, Svendsen E, Kim JH, Massey MF, Barber L, McCann RL, Hagen PO.
    J Surg Res; 1993 May 01; 54(5):451-68. PubMed ID: 8361171
    [Abstract] [Full Text] [Related]

  • 14. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts.
    Davies MG, Kim JH, Barber L, Dalen H, Svendsen E, Hagen PO.
    J Surg Res; 1994 Jul 01; 57(1):106-21. PubMed ID: 8041125
    [Abstract] [Full Text] [Related]

  • 15. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
    Zhou N, Yu QJ, Si R, Gao HK, Wang T, Gao F, Wang HC, Bian JF.
    J Cardiovasc Pharmacol; 2010 Oct 01; 56(4):402-12. PubMed ID: 20625311
    [Abstract] [Full Text] [Related]

  • 16. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
    Saunders PC, Pintucci G, Bizekis CS, Sharony R, Hyman KM, Saponara F, Baumann FG, Grossi EA, Colvin SB, Mignatti P, Galloway AC.
    J Thorac Cardiovasc Surg; 2004 May 01; 127(5):1276-84. PubMed ID: 15115983
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Influence of perioperative catheter injury on the long-term vein graft function and morphology.
    Davies MG, Dalen H, Svendsen E, Hagen PO.
    J Surg Res; 1996 Dec 01; 66(2):109-14. PubMed ID: 9024820
    [Abstract] [Full Text] [Related]

  • 20. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA, Hata JA, Williams ML, Parsa CJ, Thompson RB, Hanish SI, Gehrig TR, Koch WJ, Milano CA.
    J Thorac Cardiovasc Surg; 2005 Dec 01; 130(6):1683-90. PubMed ID: 16308016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.